Windtree Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Windtree Therapeutics has a total shareholder equity of $3.5M and total debt of $1.7M, which brings its debt-to-equity ratio to 48.7%. Its total assets and total liabilities are $28.7M and $25.2M respectively.
Key information
48.7%
Debt to equity ratio
US$1.70m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.80m |
| Equity | US$3.49m |
| Total liabilities | US$25.21m |
| Total assets | US$28.71m |
Recent financial health updates
Recent updates
Windtree Therapeutics CEO Craig Fraser - Breaking Down Acute Heart Failure (Video)
Dec 06Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions
Jul 06Shareholders Will Likely Find Windtree Therapeutics, Inc.'s (NASDAQ:WINT) CEO Compensation Acceptable
Jun 09
Should You Take Comfort From Insider Transactions At Windtree Therapeutics, Inc. (NASDAQ:WINT)?
Feb 09Financial Position Analysis
Short Term Liabilities: WINT's short term assets ($2.1M) do not cover its short term liabilities ($8.8M).
Long Term Liabilities: WINT's short term assets ($2.1M) do not cover its long term liabilities ($16.4M).
Debt to Equity History and Analysis
Debt Level: WINT has more cash than its total debt.
Reducing Debt: WINT's debt to equity ratio has increased from 39.6% to 48.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WINT has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: WINT is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.